NCT07061184View on ClinicalTrials.gov

Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

May 31, 2028

Conditions
Irritable Bowel Syndrome - DiarrhoeaTraditional Chinese Medicine (TCM)N of 1 Study DesignEfficacy and Safety
Interventions
DRUG

FLCWK

FLCWK and matching placebo to be taken in a randomised order for 9 months

DRUG

Placebo

FLCWK and matching placebo to be taken in a randomised order for 9 months

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER